Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT-A Derivation and External Validation Study.
von Haehling S, Müller-Hennessen M, Garfias-Veitl T, Goßling A, Neumann JT, Sörensen NA, Haller PM, Hartikainen T, Vollert JO, Möckel M, Blankenberg S, Westermann D, Giannitsis E. von Haehling S, et al. Among authors: vollert jo. Cells. 2023 Mar 31;12(7):1062. doi: 10.3390/cells12071062. Cells. 2023. PMID: 37048135 Free PMC article.
Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial.
Giannitsis E, Garfias-Veitl T, Slagman A, Searle J, Müller C, Blankenberg S, von Haehling S, Katus HA, Hamm CW, Huber K, Vollert JO, Möckel M. Giannitsis E, et al. Among authors: vollert jo. Cells. 2022 Jan 8;11(2):211. doi: 10.3390/cells11020211. Cells. 2022. PMID: 35053326 Free PMC article. Clinical Trial.
Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study.
Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Müller C, Muller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E. Möckel M, et al. Among authors: vollert jo. Eur Heart J. 2015 Feb 7;36(6):369-76. doi: 10.1093/eurheartj/ehu178. Epub 2014 Apr 30. Eur Heart J. 2015. PMID: 24786301 Free PMC article. Clinical Trial.
Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome.
Vafaie M, Slagman A, Möckel M, Hamm C, Huber K, Müller C, Vollert JO, Blankenberg S, Katus HA, Liebetrau C, Giannitsis E, Searle J. Vafaie M, et al. Among authors: vollert jo. Am J Med. 2016 Mar;129(3):274-82.e2. doi: 10.1016/j.amjmed.2015.10.016. Epub 2015 Oct 30. Am J Med. 2016. PMID: 26524709 Clinical Trial.
Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.
Möckel M, de Boer RA, Slagman AC, von Haehling S, Schou M, Vollert JO, Wiemer JC, Ebmeyer S, Martín-Sánchez FJ, Maisel AS, Giannitsis E. Möckel M, et al. Among authors: vollert jo. Eur J Heart Fail. 2020 Feb;22(2):267-275. doi: 10.1002/ejhf.1667. Epub 2019 Dec 12. Eur J Heart Fail. 2020. PMID: 31833168 Free article. Clinical Trial.
Copeptin: Limited Usefulness in Early Stroke Differentiation?
von Recum J, Searle J, Slagman A, Vollert JO, Endres M, Möckel M, Ebinger M. von Recum J, et al. Among authors: vollert jo. Stroke Res Treat. 2015;2015:768401. doi: 10.1155/2015/768401. Epub 2015 Jun 8. Stroke Res Treat. 2015. PMID: 26167332 Free PMC article.
39 results